Spyre Therapeutics Other Long Term Liabilities (Quarterly) Analysis

Spyre Therapeutics, Inc. (SYRE)

43.45 -0.73 (-1.65%) USD | NASDAQ | Feb 24, 16:00

43.70 +0.25 (+0.58%) After-Hours: 07:48

View Other Long Term Liabilities (Quarterly) for SYRE.
Upgrade now.

Sep '18

Jan '19

May '19

285.00

270.00

255.00

240.00

View Other Long Term Liabilities (Quarterly) Chart

Start Trial

View Historical Data

Start Trial

View Other Long Term Liabilities (Quarterly) Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

View Other Long Term Liabilities (Quarterly) Benchmarks

Start Trial

PTC Therapeutics, Inc.	Upgrade
Tandem Diabetes Care, Inc.	Upgrade
ACADIA Pharmaceuticals, Inc.	Upgrade
Alnylam Pharmaceuticals, Inc.	Upgrade
Savara, Inc.	Upgrade